Published 2 years ago

Pfizer submits application for updated COVID-19 vaccine booster to FDA

Summary by Ground News

FDA ordered vaccine makers to tweak their shots to target BA.4 and BA.5. If FDA quickly clears the combo shots, boosters could be offered within weeks. The U.S. has a contract to buy 105 million of the updated Pfizer doses. Britain a week ago became the first in the world to authorize a different update.

0 Articles

All

Left

Center

Right

The Independent

Pfizer seeks OK of updated COVID vaccine booster for fall

Pfizer has asked U.S. regulators to authorize its combination COVID-19 vaccine that adds protection against the newest omicron relatives

2 years ago·London, United Kingdom

Read Full Article

Associated Press News

Pfizer seeks OK of updated COVID vaccine booster for fall

Pfizer asked U.S. regulators Monday to authorize its combination COVID-19 vaccine that adds protection against the newest omicron relatives — a key step toward opening a fall booster campaign. The Food and Drug Administration ordered vaccine makers to tweak their shots to target BA.4 and BA.5 that are better than ever at dodging immunity from earlier vaccination or infection.

2 years ago·United States

Read Full Article

USA Today

Pfizer-BioNTech submits new COVID vaccine booster targeting BA.5 to the FDA for authorization

Pfizer and BioNTech have submitted their new COVID-19 booster that targets the omicron subvariant BA.5\u00a0to the FDA for emergency use authorization.

2 years ago·United States

Read Full Article

Hindustan Times

Pfizer files application for booster against latest variants

In a statement, the companies said they had “rapidly scaled production” for the new booster and would be able to ship doses of the new vaccine “immediately” upon emergency authorization.

2 years ago·New Delhi, India

Read Full Article

abc News

Pfizer seeks OK of updated COVID vaccine booster for fall

Pfizer has asked U.S. regulators to authorize its combination COVID-19 vaccine that adds protection against the newest omicron relatives

2 years ago·United States

Read Full Article

CNN

Pfizer and BioNTech seek FDA authorization for updated Covid-19 booster

Pfizer and BioNTech have submitted their application to the US Food and Drug Administration for emergency use authorization of their bivalent Covid-19 vaccine for use in people age 12 and older, the companies said in a statement on Monday.

2 years ago·Atlanta, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.